Demant A/S
Denmark · DK0060738599 · reports in DKK · Europe
The answers
From the annual report for the year to Dec 31, 2025. Each line says what it is based on.
- Is it growing?Fair
- Revenue +2.5% in the year to Dec 31, 2025, on the year before.
- Is it a good business?Good
- It earned 16% on its shareholders' equity in the year to Dec 31, 2025.
- Is it safe?Fair
- Equity is 25% of its assets, and operations brought in cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2025, consolidated, in DKK.
revenue
operating margin
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | DKK 19.7B | DKK 22.4B | DKK 22.4B | DKK 23.0B |
| Operating profit | DKK 3.2B | DKK 4.1B | DKK 4.5B | DKK 3.8B |
| Net profit to shareholders | DKK 2.1B | DKK 1.8B | DKK 2.4B | DKK 1.5B |
| Earnings per share | DKK 9.21 | DKK 8.04 | DKK 10.99 | DKK 7.31 |
| Cash from operations | DKK 2.6B | DKK 4.3B | DKK 4.1B | DKK 3.9B |
| Capital spending | DKK 647M | DKK 654M | DKK 576M | DKK 652M |
| Cash | DKK 1.1B | DKK 1.1B | DKK 1.1B | DKK 1.3B |
| Total assets | DKK 29.9B | DKK 30.5B | DKK 32.5B | DKK 39.1B |
| Equity | DKK 8.6B | DKK 9.3B | DKK 9.6B | DKK 9.9B |
What they do
In the company's own words, from the annual report.
The Demant Group develops, manufactures and sells products and equipment that help people with hearing loss connect and communicate with the world around them. We operate a focused hearing healthcare com-pany, consisting of three business areas: Hearing Aids, Hearing Care and Diagnostics.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.